US Patent 7135581 Antiangiogenic agents
Patent 7135581 was granted and assigned to EntreMed on November, 2006 by the United States Patent and Trademark Office.
All edits
Edits on 31 Aug, 2023
Golden AI
Edits made to:
Article (+187 characters)
Article
Patent abstract
Compositions and methods for treating mammalian disease characterized by undesirable angiogenesis by administering derivatives of 2-methoxyestradiol of the general formula:
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07135581 Antiangiogenic agents US Patent 7135581 Antiangiogenic agents
Infobox
Patent Number
0713558100
Patent Number
713558100
Edits on 28 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
071355810
Date of Patent
November 14, 2006
0Patent Application Number
099392080
Date Filed
August 24, 2001
0Official Website
Patent Primary Examiner
Edits on 27 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
071355810
Date of Patent
November 14, 2006
0Patent Application Number
099392080
Date Filed
August 24, 2001
0Official Website
Patent Primary Examiner
Edits on 8 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 19 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07135581 Antiangiogenic agents
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07135581
Date of patent
November 14, 2006
Patent application number
09939208
Date Filed
August 24, 2001
Patent primary examiner
Find more entities like US Patent 7135581 Antiangiogenic agents
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
